1-4 of 4
Joanna C. Yang, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of 210 Patients with Follicular and Marginal Zone Lymphomas Treated with 4 Gy of Radiation Therapy

Karen Chau, BA, Brandon Imber, MD MA, Erel Joffe, MDMSc, Joanna C. Yang, MD, Monica Chelius, BS, Connor Doyle, Carla Hajj, MD, Joachim Yahalom, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2827.
https://doi.org/10.1182/blood-2019-132275
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin Combined with AVD Chemotherapy and Radiotherapy in Patients with Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, Ranjana H Advani, MD, Lihua E Budde, MD PhD, Paul M. Barr, MD, Connie Lee Batlevi, MD PhD, Philip Caron, MD PhD, Louis S. Constine, MD, Savita Dandapani, MD PhD, Esther Drill, PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, Clare Grieve, BA, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T Hoppe, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, Susan Jennifer McCall, NP, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria Lia Palomba, MD, Heiko Schoder, MD, David J. Straus, MD, Shreya Vemuri, Joanna C Yang, MD MPH, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Joachim Yahalom, MD, Craig H. Moskowitz
Journal: Blood
Blood (2019) 134 (Supplement_1): 2834.
https://doi.org/10.1182/blood-2019-123150
Published: 2019
Journal Articles

Highly Favorable Outcomes with Salvage Radiation Therapy Followed By Autologous Transplant in Relapsed and Refractory DLBCL Patients with Minimal or No Response to Salvage Chemotherapy

Joanna C Yang, MD MPH, Karen Chau, BA, Michael Scordo, MD, Craig S. Sauter, MD, Joachim Yahalom, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4137.
https://doi.org/10.1182/blood-2019-131664
Published: 2019
Journal Articles

A Pilot Study of Brentuximab Vedotin and AVD Chemotherapy Followed By 20 Gy Involved-Site Radiotherapy in Early Stage, Unfavorable Risk Hodgkin Lymphoma

Anita Kumar, MD, Carla Casulo, MD, Ranjana H. Advani, MD, Lihua Budde, MD PhD, Paul M. Barr, MD, Connie L. Batlevi, MD PhD, Philip Caron, MD PhD, Robert W. Chen, MD, Louis S. Constine, MD, Amanda Courtien, Savita Dandapani, MD PhD, Pamela Drullinsky, MD, Jonathan W. Friedberg, MD, John Gerecitano, MD PhD, Audrey Hamilton, MD, Paul A. Hamlin, MD, Richard T. Hoppe, MD, Steven M. Horwitz, MD, Matthew J. Matasar, MD, Shoshana T. Miller, Alison J. Moskowitz, MD, Ariela Noy, MD, Maria L. Palomba, MD, Carol S. Portlock, MD, Heiko Schoder, MD, David J. Straus, MD, Joanna C. Yang, MD, Anas Younes, MD, Andrew D. Zelenetz, MD PhD, Zhigang Zhang, PhD, Joachim Yahalom, MD, Craig H. Moskowitz, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 734.
https://doi.org/10.1182/blood.V130.Suppl_1.734.734
Published: 2017